Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 36

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 36
---
 the Company’s Nominating and Governance Committee reviewed and pre-approved related party transactions with Joseph Barrett Fitzgerald and Robert Blaise Fitzgerald, the sons of Joseph Fitzgerald, our Executive Vice President and Group President, Cardiology. Joseph Barrett Fitzgerald and Robert Blaise Fitzgerald are both employed as AF Solutions Territory Managers within our Electrophysiology business. During 2024, Joseph Barrett Fitzgerald and Robert Blaise Fitzgerald each earned total compensation, including base salary and commissions, of approximately $674,731 and $896,129, respectively. Most of this compensation was comprised of commissions earned under the Company’s sales compensation plans. The base salary and commissions payments for Joseph Barrett Fitzgerald and Robert Blaise Fitzgerald were commensurate with those of other employees in similar positions with comparable sales results and targets.

#### Code of Conduct
We maintain a Code of Conduct, which has been approved by our Board, to ensure our directors, employees and officers, including our Chief Executive Officer and Chief Financial Officer, understand the basic principles that govern our corporate conduct. The Code of Conduct is available on our website at https://investors.bostonscientific.com/environmental-social-governance/governance-overview . A stockholder may request a copy of the Code of Conduct by contacting our Corporate Secretary at Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough, Massachusetts 01752. Any waivers or substantive amendments of the Code of Conduct will be disclosed on our website at https://investors.bostonscientific.com/environmental-social-governance/governance-overview.

#### Corporate Responsibility
We endeavor to conduct our operations in a responsible and ethical manner, develop innovative products that improve health care worldwide and advance the growth and capabilities of our employees, while also engaging with and supporting the communities where we operate and reducing our environmental footprint. By proactively addressing energy consumption, carbon output, waste management, and water use, we are making measurable progress toward shaping a better future for our planet, which directly impacts the well-being of our patients, customers, employees, communities, and investors. Using our Global Energy Management System, we implement our C3 strategy — Cut, Convert, Compensate — to cut energy use, convert to renewable sources instead of fossil fuels, and compensate with carbon offset projects for remaining unavoidable emissions. This strategy helps us make progress towards our sustainability goals. In recognition of our progress toward these goals and our other social and environmental policies, we were selected for inclusion in the Dow Jones Sustainability Index North America (DJSI) for the fifth consecutive year.